Abbott 获得 FDA 批准 CardioMEMS 心衰监测系统的患者端更新
Abbott gets FDA nod for updates to heart failure monitoring system
Abbott 的 CardioMEMS 心衰监测系统更新获得 FDA 批准,允许患者通过手机应用查看肺动脉压读数,并接收个性化的药物调整指令。该公司表示这些更新旨在帮助患者在门诊间隙更好地管理自身病情,而基于肺动脉压变化的动态治疗计划功能预计将于今年晚些时候推出。
Dive Brief:
- Abbott received Food and Drug Administration approval for updates to its heart monitoring implant that allow patients to be more involved in their care.
- The company’s CardioMEMS device, first approved in 2014, is a small sensor implanted in the pulmonary artery to measure pulmonary artery pressure and send notifications of worsening heart failure.
- The updates will allow patients to view their pulmonary artery pressure readings for the first time and receive personalized medication updates through a smartphone app, Abbott said Monday.
Dive Insight:
Abbott said the updates will help patients stay informed and connected between doctor visits. CardioMEMS was developed to detect the signs of worsening heart failure before symptoms appear. As heart failure gets worse, pressure in the artery between the heart and the lungs can rise.
"Heart failure can worsen before patients notice shortness of breath, swelling or weight gain,” said Dr. Andrew Sauer, a cardiologist and vice president for research at Saint Luke’s Mid America Heart Institute, in a statement from Abbott. “Pulmonary artery pressure readings can help identify changes earlier, giving care teams an opportunity to adjust treatment before symptoms develop.”
In addition to letting patients view their readings, the CardioMEMS updates include a software feature that allows clinicians to adjust medications based on changes in pulmonary artery pressure. The feature, called dynamic treatment plan, can send instructions directly to patients through an app.
Abbott said it expects to make dynamic treatment plans and the CardioGuide HF App available later this year.
Earlier this year, Abbott received an FDA nod for a version of CardioMEMS with a much smaller reader. CardioMEMS received a national coverage determination from the Centers for Medicare and Medicaid Services in 2025.
来源:MedTech Dive 器械媒体 · medtechdive.com